St. Luke's Cardiology Associates
Bethlehem, Pennsylvania, United States
Cardiologist in Bethlehem, Pennsylvania
1469 8th Ave, Bethlehem, PA 18018
About St. Luke's Cardiology Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at St. Luke's Cardiology Associates
During the past decade, St. Luke's Cardiology Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
2018-08-30
2023-01-30
Active, not recruiting
600
Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy
2020-10-30
2024-08-31
Active, not recruiting
60
ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration
2021-07-08
2023-04-01
Recruiting
30
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD
2021-03-04
2025-09-01
Active, not recruiting
1,200
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Cardiology Associates"
#1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at St. Luke's Cardiology Associates
According to Clinical.Site data, the most researched conditions in "St. Luke's Cardiology Associates" are
"Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials), "Non-obstructive Hypertrophic Cardiomyopathy" (1 trials) and "Obstructive Hypertrophic Cardiomyopathy" (1 trials). Many other conditions were trialed in "St. Luke's Cardiology Associates" in a lesser frequency.
Clinical Trials Intervention Types at St. Luke's Cardiology Associates
Most popular intervention types in "St. Luke's Cardiology Associates" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "mavacamten" (2 trials), "Apixaban" (1 trials) and "Non-Interventional" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St. Luke's Cardiology Associates
The vast majority of trials in "St. Luke's Cardiology Associates" are
4 trials for "All" genders.
Clinical Trials Status at St. Luke's Cardiology Associates
Currently, there are NaN active trials in "St. Luke's Cardiology Associates".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in St. Luke's Cardiology Associates,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in St. Luke's Cardiology Associates, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".